Reducing transplant toxicity

被引:11
作者
Feinstein, L
Storb, R
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program transplantat Biol, Seattle, WA 98109 USA
[2] Univ Washington, Sch Med, Div Oncol, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1097/00062752-200111000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Conventional myeloablative allogeneic hematopoietic cell transplantation produces considerable morbidity and mortality. These generally limit this treatment to patients in good medical condition who are younger than 55 years of age. T-cell-mediated graft-versus-tumor effects play a key role in the elimination of malignancy after allografting. Several investigators have sought to reduce regimen-related toxicities while optimizing graft-versus-tumor effects. Strategies can be broadly classified as (1) reduced-intensity regimens that retain some toxicity, and (2) minimally myelosuppressive regimens that rely on immunosuppression for allogeneic engraftment and resultant graft-versus-tumor effects. Although follow-up has been short, preliminary results are encouraging. Current challenges include defining a regimen that will facilitate full donor engraftment while minimizing toxicities and graft-versus-host disease. If long-term efficacy is demonstrated, such strategies will expand the options for patients who would not qualify for conventional allogeneic transplants. (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:342 / 348
页数:7
相关论文
共 57 条
[1]   Nonmyeloablative stem cell transplantation for congenital immunodeficiencies [J].
Amrolia, P ;
Gaspar, HB ;
Hassan, A ;
Webb, D ;
Jones, A ;
Sturt, N ;
Mieli-Vergani, G ;
Pagliuca, A ;
Mufti, G ;
Hadzic, N ;
Davies, G ;
Veys, P .
BLOOD, 2000, 96 (04) :1239-1246
[2]   Long-term survive of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation [J].
Andreani, M ;
Nesci, S ;
Lucarelli, G ;
Tonucci, P ;
Rapa, S ;
Angelucci, E ;
Persini, B ;
Agostinelli, F ;
Donati, M ;
Manna, M .
BONE MARROW TRANSPLANTATION, 2000, 25 (04) :401-404
[3]   Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia [J].
Andreani, M ;
Manna, M ;
Lucarelli, G ;
Tonucci, P ;
Agostinelli, F ;
Ripalti, M ;
Rapa, S ;
Talevi, N ;
Galimberti, M ;
Nesci, S .
BLOOD, 1996, 87 (08) :3494-3499
[4]  
ANTIN JH, 1992, BLOOD, V80, P2964
[5]   Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. [J].
Bensinger, WI ;
Martin, PJ ;
Storer, B ;
Clift, R ;
Forman, SJ ;
Negrin, R ;
Kashyap, A ;
Flowers, MED ;
Lilleby, K ;
Chauncey, TR ;
Storb, R ;
Appelbaum, FR ;
Rowley, S ;
Heimfeld, S ;
Blume, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) :175-181
[6]   Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma [J].
Carella, AM ;
Cavaliere, M ;
Lerma, E ;
Ferrara, R ;
Tedeschi, L ;
Romanelli, A ;
Vinci, M ;
Pinotti, G ;
Lambelet, P ;
Loni, C ;
Verdiani, S ;
De Stefano, F ;
Valbonesi, M ;
Corsetti, MT .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :3918-3924
[7]   The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse [J].
Carlens, S ;
Remberger, M ;
Aschan, J ;
Ringdén, O .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (01) :31-38
[8]  
Champlin RE, 2000, BLOOD, V95, P3702
[9]   Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses [J].
Childs, R ;
Clave, E ;
Contentin, N ;
Jayasekera, D ;
Hensel, N ;
Leitman, S ;
Read, EJ ;
Carter, C ;
Bahceci, E ;
Young, NS ;
Barrett, AJ .
BLOOD, 1999, 94 (09) :3234-3241
[10]   Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation [J].
Childs, R ;
Chernoff, A ;
Contentin, N ;
Bahceci, E ;
Schrump, D ;
Leitman, S ;
Read, EJ ;
Tisdale, J ;
Dunbar, C ;
Linehan, WM ;
Young, NS ;
Barrett, AJ ;
Clave, E ;
Epperson, D ;
Mayo, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (11) :750-758